Di Lenarda, A.; Di Gesaro, G.; Sarullo, F.M.; Miani, D.; Driussi, M.; Correale, M.; Bilato, C.; Passantino, A.; Carluccio, E.; Villani, A.;
et al. Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study). J. Clin. Med. 2023, 12, 699.
https://doi.org/10.3390/jcm12020699
AMA Style
Di Lenarda A, Di Gesaro G, Sarullo FM, Miani D, Driussi M, Correale M, Bilato C, Passantino A, Carluccio E, Villani A,
et al. Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study). Journal of Clinical Medicine. 2023; 12(2):699.
https://doi.org/10.3390/jcm12020699
Chicago/Turabian Style
Di Lenarda, Andrea, Gabriele Di Gesaro, Filippo Maria Sarullo, Daniela Miani, Mauro Driussi, Michele Correale, Claudio Bilato, Andrea Passantino, Erberto Carluccio, Alessandra Villani,
and et al. 2023. "Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study)" Journal of Clinical Medicine 12, no. 2: 699.
https://doi.org/10.3390/jcm12020699
APA Style
Di Lenarda, A., Di Gesaro, G., Sarullo, F. M., Miani, D., Driussi, M., Correale, M., Bilato, C., Passantino, A., Carluccio, E., Villani, A., degli Esposti, L., d’Agostino, C., Peruzzi, E., Poli, S., & Iacoviello, M.
(2023). Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study). Journal of Clinical Medicine, 12(2), 699.
https://doi.org/10.3390/jcm12020699